MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Exelixis Inc

EXEL

#690
Exelixis Inc
44.0600
-0.83%
Sector:
Base:
Profit Currency:
Daily Range
44.0600
44.0600
Year Range
36.0000
47.2360
Daily Change
-0.83%
Monthly Change
+1.26%
6 month change
+12.86%
Year Change
+12.86%
Previous Close
44.4300
Open
44.0600
Bid
Ask
Low
44.0600
High
44.0600
Volume
359
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. EXEL
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24 TTM

Exelixis Inc

Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.

News

Investing Investing
EXEL
2 days ago, 23:48
Aftab Dana sells EXEL stock worth $2.1m
Investing Investing
EXEL
2026.02.21
Exelixis director Wyszomierski sells $4.38 million in stock
Seeking Alpha Seeking Alpha
PLTR MU TSLA COST CVNA
2026.02.20
Tracking Renaissance Technologies (RenTec) 13F Portfolio – Q4 2025 Update
Investing Investing
JNJ EXEL FAF KKR DKNG
2026.02.19
Wednesday’s Insider Activity: Kennedy’s $4M Bet on First American
Investing Investing
EXEL
2026.02.19
Exelixis director Eckhardt sells $168k in stock
Zacks Zacks
EXEL
2026.02.16
A Dive into Exelixis (EXEL) International Revenue Trends and Forecasts
Zacks Zacks
ALKS EXEL AGIO CSTL
2026.02.13
Agios Pharmaceuticals Incurs Narrower-Than-Expected Q4 Loss
Zacks Zacks
NVS ALKS EXEL
2026.02.13
NVS Reports Positive Late-Stage Data on Kidney Disease Drug Vanrafia
Zacks Zacks
EXEL
2026.02.13
Here's Why Exelixis (EXEL) is a Strong Value Stock
Zacks Zacks
EXEL LQDA
2026.02.12
EXEL or LQDA: Which Is the Better Value Stock Right Now?
Zacks Zacks
PFE ALKS EXEL MDGL
2026.02.12
MDGL Strengthens MASH Franchise With New Genetic Approaches
Zacks Zacks
ALKS EXEL ZTS CSTL
2026.02.12
Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd